Table 1.
Extent of neonatal perirhinal lesions.
| Subjects | PRh | ERh | ||||||
|---|---|---|---|---|---|---|---|---|
| L% | R% | X% | W% | L% | R% | X% | W% | |
| Neo-PRh-1 | 89.76 | 79.91 | 83.34 | 69.04 | 28.51 | 2.28 | 15.39 | 0.65 |
| Neo-PRh-2 | 68.16 | 70.58 | 69.37 | 48.11 | 17.72 | 20.65 | 19.19 | 3.36 |
| Neo-PRh-3 | 65.45 | 81.02 | 73.23 | 53.02 | 7.72 | 3.12 | 5.42 | 0.24 |
| Neo-PRh-4 | 59.40 | 74.73 | 67.06 | 44.39 | 11.55 | 17.84 | 14.69 | 2.06 |
| Neo-PRh-5 | 75.90 | 66.81 | 71.35 | 50.71 | 38.60 | 29.86 | 34.32 | 11.53 |
| Neo-PRh-6 | 74.12 | 80.31 | 77.22 | 59.53 | 25.34 | 43.64 | 34.49 | 11.06 |
| Average | 72.13 | 75.06 | 73.60 | 54.13 | 21.57 | 19.57 | 20.57 | 4.87 |
L%, percent damage to left hemisphere; R%, percent damage to right hemisphere; X%, average damage to both hemispheres; W%, weighted damage to both hemispheres [W% = (L% × R%)/100]. PRh, perirhinal cortex; ERh, entorhinal cortex. Lesion extents from cases Neo-PRh-1 thru Neo-PRh-6 were previously reported in Zeamer et al. (2015).